Amgen (AMGN) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to -$25.1 billion.
- Amgen's Retained Earnings rose 899.96% to -$25.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$25.1 billion, marking a year-over-year increase of 899.96%. This contributed to the annual value of -$25.1 billion for FY2025, which is 899.96% up from last year.
- Amgen's Retained Earnings amounted to -$25.1 billion in Q4 2025, which was up 899.96% from -$23.8 billion recorded in Q3 2025.
- In the past 5 years, Amgen's Retained Earnings ranged from a high of -$21.6 billion in Q1 2021 and a low of -$29.6 billion during Q1 2022
- Moreover, its 5-year median value for Retained Earnings was -$26.1 billion (2023), whereas its average is -$26.0 billion.
- Per our database at Business Quant, Amgen's Retained Earnings plummeted by 3664.22% in 2022 and then skyrocketed by 1102.76% in 2023.
- Over the past 5 years, Amgen's Retained Earnings (Quarter) stood at -$24.6 billion in 2021, then decreased by 16.35% to -$28.6 billion in 2022, then rose by 7.24% to -$26.5 billion in 2023, then fell by 3.92% to -$27.6 billion in 2024, then increased by 9.0% to -$25.1 billion in 2025.
- Its Retained Earnings was -$25.1 billion in Q4 2025, compared to -$23.8 billion in Q3 2025 and -$25.7 billion in Q2 2025.